Incap Oyj (LON:0ERY)
9.39
+0.55 (6.29%)
At close: Oct 27, 2025
Incap Oyj Revenue
Incap Oyj had revenue of 55.29M EUR in the quarter ending June 30, 2025, a decrease of -4.08%. This brings the company's revenue in the last twelve months to 229.66M, up 13.95% year-over-year. In the year 2024, Incap Oyj had annual revenue of 231.17M with 4.29% growth.
Revenue (ttm)
229.66M EUR
Revenue Growth
+13.95%
P/S Ratio
1.24
Revenue / Employee
255.18K EUR
Employees
900
Market Cap
243.16M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 231.17M | 9.51M | 4.29% |
| Dec 31, 2023 | 221.66M | -42.16M | -15.98% |
| Dec 31, 2022 | 263.82M | 94.01M | 55.36% |
| Dec 31, 2021 | 169.81M | 62.50M | 58.24% |
| Dec 31, 2020 | 107.31M | 35.31M | 49.04% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 198.54B |
| BP p.l.c. | 134.89B |
| Unilever | 51.24B |
| AstraZeneca | 41.24B |
| HSBC Holdings | 41.03B |
| Rio Tinto Group | 39.22B |
| GSK plc | 31.63B |
| British American Tobacco p.l.c. | 25.60B |